Clinical Trial Detail

NCT ID NCT02802267
Title Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hybrigenics Corporation
Indications

acute myeloid leukemia

Therapies

Decitabine + Inecalcitol

Decitabine

Age Groups: senior

No variant requirements are available.